Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2).
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2023)
Abstract
ClinicalTrials.gov, NCT04179669.
MoreTranslated text
Key words
HeFH,LDL-C,PCSK9,Tafolecimab
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined